1. Market Research
  2. > Cancer Industry

Lymphoma Industry, July 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Leukemia, Bone Marrow Transplant, Nuclear Imaging Equipment, Pap Smear, Nuclear Medicine, Blood Disease, Cancer Diagnostic, Monoclonal Antibody, Prostate Cancer.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements ...

Global Lymphoma Partnering 2010 to 2016

Global Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies . The Global Therapy Partnering Terms and Agreements since 2010 ...

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016 Summary Global Markets ...

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 2 (Transcriptional ...

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016’, provides in depth analysis on Histone ...

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global ...

Liposarcoma - Pipeline Review, H1 2016

Liposarcoma - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liposarcoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2016’, provides an overview of the Liposarcoma pipeline landscape. The report provides comprehensive ...

About 4 300 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • January 2016
    178 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.